vs
Side-by-side financial comparison of ARGENX SE (ARGX) and Molson Coors Beverage Company (TAP). Click either name above to swap in a different company.
Molson Coors Beverage Company is the larger business by last-quarter revenue ($2.7B vs $2.5B, roughly 1.1× ARGENX SE). ARGENX SE runs the higher net margin — 35.5% vs 5.5%, a 29.9% gap on every dollar of revenue. On growth, ARGENX SE posted the faster year-over-year revenue change (83.2% vs 2.0%).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
Molson Coors Beverage Company is a Canadian-American multinational drink and brewing company headquartered in Chicago, Illinois and Montreal, Quebec.
ARGX vs TAP — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.5B | $2.7B |
| Net Profit | $877.2M | $150.1M |
| Gross Margin | 89.5% | 33.0% |
| Operating Margin | 28.9% | — |
| Net Margin | 35.5% | 5.5% |
| Revenue YoY | 83.2% | 2.0% |
| Net Profit YoY | 1.3% | 25.0% |
| EPS (diluted) | $13.25 | $0.80 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $2.7B | ||
| Q4 25 | $2.5B | $3.1B | ||
| Q3 25 | — | $3.5B | ||
| Q2 25 | $1.8B | $3.7B | ||
| Q1 25 | — | $2.7B | ||
| Q4 24 | $1.4B | $3.2B | ||
| Q3 24 | — | $3.6B | ||
| Q2 24 | $901.9M | $3.8B |
| Q1 26 | — | $150.1M | ||
| Q4 25 | $877.2M | $238.3M | ||
| Q3 25 | — | $-2.9B | ||
| Q2 25 | $414.8M | $428.7M | ||
| Q1 25 | — | $121.0M | ||
| Q4 24 | $865.6M | $287.8M | ||
| Q3 24 | — | $199.8M | ||
| Q2 24 | $-32.5M | $427.0M |
| Q1 26 | — | 33.0% | ||
| Q4 25 | 89.5% | 31.0% | ||
| Q3 25 | — | 33.7% | ||
| Q2 25 | 89.2% | 34.3% | ||
| Q1 25 | — | 31.6% | ||
| Q4 24 | 90.2% | 32.0% | ||
| Q3 24 | — | 33.4% | ||
| Q2 24 | 89.4% | 34.6% |
| Q1 26 | — | — | ||
| Q4 25 | 28.9% | 10.4% | ||
| Q3 25 | — | -98.5% | ||
| Q2 25 | 19.2% | 15.6% | ||
| Q1 25 | — | 6.9% | ||
| Q4 24 | 8.7% | 12.0% | ||
| Q3 24 | — | 12.5% | ||
| Q2 24 | -15.4% | 15.6% |
| Q1 26 | — | 5.5% | ||
| Q4 25 | 35.5% | 7.6% | ||
| Q3 25 | — | -84.0% | ||
| Q2 25 | 23.4% | 11.5% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | 64.1% | 8.9% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | -3.6% | 11.1% |
| Q1 26 | — | $0.80 | ||
| Q4 25 | $13.25 | $1.32 | ||
| Q3 25 | — | $-14.79 | ||
| Q2 25 | $6.32 | $2.13 | ||
| Q1 25 | — | $0.59 | ||
| Q4 24 | $13.33 | $1.39 | ||
| Q3 24 | — | $0.96 | ||
| Q2 24 | $-0.55 | $2.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.5B | $382.6M |
| Total DebtLower is stronger | — | $3.8B |
| Stockholders' EquityBook value | $7.3B | $10.3B |
| Total Assets | $8.7B | $22.4B |
| Debt / EquityLower = less leverage | — | 0.38× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $382.6M | ||
| Q4 25 | $3.5B | $896.5M | ||
| Q3 25 | — | $950.2M | ||
| Q2 25 | $2.1B | $613.8M | ||
| Q1 25 | — | $412.7M | ||
| Q4 24 | $1.5B | $969.3M | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | $1.4B | $1.6B |
| Q1 26 | — | $3.8B | ||
| Q4 25 | — | $6.3B | ||
| Q3 25 | — | $6.3B | ||
| Q2 25 | — | $6.3B | ||
| Q1 25 | — | $6.2B | ||
| Q4 24 | — | $6.1B | ||
| Q3 24 | — | $6.2B | ||
| Q2 24 | $11.0M | $7.0B |
| Q1 26 | — | $10.3B | ||
| Q4 25 | $7.3B | $10.2B | ||
| Q3 25 | — | $10.3B | ||
| Q2 25 | $6.1B | $13.4B | ||
| Q1 25 | — | $13.1B | ||
| Q4 24 | $5.5B | $13.1B | ||
| Q3 24 | — | $13.3B | ||
| Q2 24 | $4.3B | $13.2B |
| Q1 26 | — | $22.4B | ||
| Q4 25 | $8.7B | $22.7B | ||
| Q3 25 | — | $22.9B | ||
| Q2 25 | $7.2B | $26.8B | ||
| Q1 25 | — | $25.9B | ||
| Q4 24 | $6.2B | $26.1B | ||
| Q3 24 | — | $26.6B | ||
| Q2 24 | $4.8B | $27.4B |
| Q1 26 | — | 0.38× | ||
| Q4 25 | — | 0.61× | ||
| Q3 25 | — | 0.61× | ||
| Q2 25 | — | 0.47× | ||
| Q1 25 | — | 0.47× | ||
| Q4 24 | — | 0.47× | ||
| Q3 24 | — | 0.47× | ||
| Q2 24 | 0.00× | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $323.3M | — |
| Free Cash FlowOCF − Capex | $322.4M | — |
| FCF MarginFCF / Revenue | 13.0% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | 0.37× | — |
| TTM Free Cash FlowTrailing 4 quarters | $594.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $323.3M | $540.7M | ||
| Q3 25 | — | $616.1M | ||
| Q2 25 | $361.8M | $718.3M | ||
| Q1 25 | — | $-90.7M | ||
| Q4 24 | $41.9M | $494.5M | ||
| Q3 24 | — | $521.2M | ||
| Q2 24 | $-124.7M | $869.2M |
| Q1 26 | — | — | ||
| Q4 25 | $322.4M | $357.8M | ||
| Q3 25 | — | $483.0M | ||
| Q2 25 | $356.6M | $555.0M | ||
| Q1 25 | — | $-328.0M | ||
| Q4 24 | $40.9M | $383.4M | ||
| Q3 24 | — | $350.4M | ||
| Q2 24 | $-125.5M | $691.7M |
| Q1 26 | — | — | ||
| Q4 25 | 13.0% | 11.4% | ||
| Q3 25 | — | 13.9% | ||
| Q2 25 | 20.1% | 14.8% | ||
| Q1 25 | — | -12.2% | ||
| Q4 24 | 3.0% | 11.8% | ||
| Q3 24 | — | 9.7% | ||
| Q2 24 | -13.9% | 18.0% |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 5.9% | ||
| Q3 25 | — | 3.8% | ||
| Q2 25 | 0.3% | 4.4% | ||
| Q1 25 | — | 8.8% | ||
| Q4 24 | 0.1% | 3.4% | ||
| Q3 24 | — | 4.7% | ||
| Q2 24 | 0.1% | 4.6% |
| Q1 26 | — | — | ||
| Q4 25 | 0.37× | 2.27× | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.87× | 1.68× | ||
| Q1 25 | — | -0.75× | ||
| Q4 24 | 0.05× | 1.72× | ||
| Q3 24 | — | 2.61× | ||
| Q2 24 | — | 2.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
